of RNAi in flies (Fig. 1a) . To test the effectiveness of Valium20, we generated several fly lines containing shRNA constructs that target genes associated with either distinctive germline or maternal effect phenotypes. We induced shRNA expression speci fically in the germline with MTD-Gal4 (ref. 6 ), a line that carries three Gal4 drivers expressed at various stages during oogenesis (Online Methods). For all examined lines, we recovered the expected oogenesis and maternal effect mutant phenotypes (Supplementary Note 1), indicating that shRNAs triggered potent gene knockdown during oogenesis (Fig. 1b,c) . To deter mine whether maternal expression of shRNAs can also block expression of zygotically expressed genes, we generated shRNAs to a few zygotic genes that result in embryonic lethality when mutated. In all cases, we observed the expected phenotypes as shown for decapentaplegic (dpp; Fig. 1c ). Finally, we tested the effectiveness of shRNAs expressed from Valium20 in somatic tissues. In general, the obtained phenotypes were stronger than those obtained with the longhairpin-based vector Valium10 and resembled genetic null mutations for the respective genes (Fig. 1d,e and Supplementary Fig. 3 ).
Whereas shRNAs expressed from Valium20 generated effective knockdown phenotypes in germline and soma, the phenotypic penetrance in the germline was influenced by temperature and maternal age, indicating room for improvement (Supplementary Note 1). We therefore generated Valium22 ( Supplementary  Fig. 2 ) based on the UASp vector 7 , which is optimized for trans gene expression in the female germline. Indeed, Valium22 mediated knockdowns in the germline were overall stronger than those generated using Valium20. We note, however, that Valium22 did not allow robust transgene expression in the soma, leading to incomplete somatic knockdowns (data not shown).
We chose the ovarian Piwiinteracting RNA (piRNA) pathway as a system to compare the efficacies and specificities of Valium20 and Valium22. Both somatic and germline cells of the Drosophila ovary produce piRNAs to silence transposable elements, but the pathway architecture differs in both cell types 8 . We generated multiple shRNA lines targeting proteins with a role in the piRNA pathway. Consistent with the strong knockdown observed for each target (Fig. 2a) , RNAi phenotypes generated using the maternal MTD-Gal4 line and Valium22 were highly reminiscent of each published null mutant. Depletion of the proteins Piwi, Aub, SpnE or Armi resulted in complete sterility (Fig. 2b) , and we observed strong derepression of three transposable elements known to be targets of the germline piRNA pathway by quantitative reverse transcription-PCR (RTPCR) or by antibody staining (Fig. 2c,d) existing transgenic rnai resources in Drosophila melanogaster based on long double-stranded hairpin rnas are powerful tools for functional studies, but they are ineffective in gene knockdown during oogenesis, an important model system for the study of many biological questions. We show that shrnas, modeled on an endogenous microrna, are extremely effective at silencing gene expression during oogenesis. We also describe our progress toward building a genome-wide shrna resource.
Current Drosophila transgenic RNAi resources use long hairpins as silencing triggers 1 . However, for reasons unknown, long hairpins are ineffective for gene silencing in the female germline, a conclu sion that we reached after extensive testing of various construct designs ( Supplementary Fig. 1 and Supplementary Note 1) . In Drosophila, RNAi can be triggered via distinct routes, each of which generates small silencing RNAs via discrete processing and loading machineries 2 . In particular, artificial microRNAs, referred to as shRNAs, have been shown to trigger effective silenc ing in somatic cells 3 and in the female germline in one case 4 . As shRNAs have not been used extensively and compared to long hairpins for their efficacies, we systematically evaluated their use as a transgenic trigger of RNAi in Drosophila.
We constructed Valium20, a vector that combines the opti mized expression features of the previously reported Valium10 for somatic RNAi 5 with a modified scaffold of the microRNA miR1 ( Fig. 1a and Supplementary Fig. 2 ). Unique cloning sites allow the generation of shRNAs that accommodate the desired sequences, leading to a hairpin with perfect duplex structure, which favors shRNA loading into AGO2, the principal effector Lossoffunction mutations in tudor are known to have no impact on transposon silencing in the germline or on fertility, but these mutants are defective in Aub localization to the posterior end of the growing oocyte. This leads to a failure in the specification of primordial germ cells and results in a 'grandchildless' phenotype. We observed all of these characteristics in the shRNA-tud (shRNA to the tudor gene) transgenic flies (data not shown). Typically, we observed similar phenotypes when we tested the same shRNAs with Valium20. However, Valium20mediated knockdown of Piwi or Armi led to more severe phenotypes. This is in full agreement with data for their respective genetic null mutants, as it has been shown that the function of Piwi and Armi in the somatic support cells of the ovary is critical for germline development and therefore ovarian morphology. This indicates leaky shRNA expression from Valium20 transgenes in somatic ovarian cells (Supplementary Table 1 , Supplementary Fig. 4 and Supplementary Note 1). We suspect that a temperaturesensitive element present in the hsp70 minimal promoter of Valium20 causes lowlevel expression that, in combination with basal Gal4 levels, leads to shRNA expres sion sufficient for gene knockdowns in the soma. Altogether, our results indicate that Valium22 is not only more effective for knockdowns in the germline but is also superior in terms of tissue specificity as the effects appear to be strictly restricted to the female germline.
It was important to understand the biogenesis requirements, processing accuracy and loading characteristics of shRNAs, which are designed to take advantage of different aspects of the mostly distinct fly miRNA and siRNA pathways to favor loading into AGO2, the major RNAi machinery in Drosophila. Our analysis indicated that shRNAs are processed by the sequential action of DroshaPasha and Dicer1LoqsPB complexes followed by load ing into AGO1 and AGO2 proteins ( Supplementary Figs. 5a ,b and 6 and Supplementary Note 1). Loading into AGO2 required Dcr2 and presumably also R2D2 and perfect basepairing at positions 9 and 10 of the siRNA, as has been shown for endog enous siRNAs. Immunopurification experiments indicated that shRNAs are efficiently loaded into AGO2 as intended but that a fraction is also associated with AGO1. Small RNA sequencing efforts from cultured Drosophila cells transfected with three dif ferent Valium20 constructs showed that shRNAs are accurately processed at the intended 5′ ends. Furthermore, the amount of mature shRNA strands accumulated at levels comparable to those of the most abundant cellular microRNA (miR) strands and exceed miR complementary strand (miR*)passenger strand strand levels several fold as predicted from the differences in thermodynamic stability of guide and passenger strand 5′ ends.
RNAi approaches can suffer from unspecific targeting of genes exhibiting sufficient sequence complementarity to the experi mental siRNA (referred to as offtarget effects) 9 . In compari son to longhairpin constructs, shRNA constructs are expected to be advantageous as they give rise to only two siRNA species, the guide and passenger strands ( Supplementary Fig. 6 and Supplementary Note 1). We minimized offtarget effects caused by extended complementarity by filtering out shRNAs whose guide or passenger strands have complementary matches of 16 nucleotides or more to the fly transcriptome. As shRNAs are partially loaded into AGO1, they could also produce offtarget effects through fortuitous recognition of mRNAs via the 'seed' region leading to miRNAlike repression 10 . To address the prob lem of offtarget effects experimentally, we generated several shRNA lines targeting genes that are not required for viability. Only one line out of eight tested was associated with unexpected lethality (Supplementary Table 2 ). This is similar to what has been observed with long hairpins 5, 11 . Thus, offtarget effects with shRNAs are still a matter of concern, and we suggest verification of obtained phenotypes using independent shRNA constructs to the same gene.
Encouraged by the remarkable silencing potency of shRNAs, we started to generate a largescale community resource for trans genic RNAi in Drosophila (http://www.flyrnai.org/TRiPHOME. html). As of March 2011, we have constructed over 2,900 fly stocks (an updated list is available at the Transgenic RNAi Project (TRiP) homepage), and they are available from the Bloomington Drosophila Stock Center. We aim to construct shRNAs to all 14,208 annotated Drosophila proteincoding genes (genome release 5). Toward this end, we predicted shRNA sequences for all genes using designer of small interfering RNA (DSIR) 12 shRNAs for effective knockdown in trans genic flies, and the vast majority of the shRNAs described in this paper were desi gned using the DSIR algorithm. We synthe sized 83,256 unique shRNA oligonucleotides in situ on four custom glassslide microarrays 13 . We amplified these as pools, and inserted them into Valium20 and Valium22. We analyzed ~160,000 indi vidual clones per vector, and identified accurate clones through either conventional sequencing or a twostep process involving DNA Sudoku 14 compression followed by Illumina sequencing. We anticipate that at least 8,000 constructs per year will become avail able from the TRiP for distribution to the community. online methods Drosophila strains. The maternal triple driver (MTD)-Gal4 stock 6 was a gift from L. Cooley (Yale University). The stock contained homozygous insertions of three Gal4 constructs, which together provide robust germline and maternal Gal4 expression. The genotype was P{COG-Gal4:VP16}; P{Gal4-nos.NGT}40; P{nos-Gal4-VP16} (Bloomington stock 31777). P{COG-Gal4:VP16} 7 contained a promoter from the otu gene and the 3′ untranslated region (UTR) from the K10 gene. Gal4:VP16 expression from this transgene was weak or absent in the germarium and robust beginning in stage1 egg chambers. P{nos-Gal4-VP16} con tained both the promoter and 3′ UTR from the nanos gene 15 and was expressed throughout the germarium and in all stages of egg chambers, with lower expression in young egg chambers (~stages 2-6) 7 . P{Gal4-nos.NGT}40 contained the nanos promoter and αTub84E 3′ UTR 16 , and was made for maternal loading of Gal4 to drive expression during embryogenesis. GMR-Gal4 and C96-Gal4 were used to drive expression in the eye and wing, respectively, as described previously 5 . Their descriptions are available from FlyBase (http://flybase. org/). Details on the full genotype of all the lines used in this study are available on the TRiP website (http://www.flyrnai.org/ TRiPHOME.html).
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Phenotypic analyses. For DAPI staining, ovaries were dissected in PBS and fixed in 4% electron microscopy (EM)grade para formaldehyde (Electron Microscopy Sciences) diluted in PBS for 30 min. Ovaries were counterstained with DAPI (Invitrogen) for 10 min. Embryonic cuticles and wings were prepared as described previously 17, 18 . For immunofluorescence, ovaries were dissected from 3-5dayold flies into icecold PBS and subsequently fixed in 4% formaldehyde (Thermo Scientific) containing 0.15% Triton X 100 (SigmaAldrich), diluted in PBS, for 25 min. After three rinses with PBT (PBS with 0.3% Triton X 100) ovaries were blocked in BBX (PBS containing 0.3% Triton X 100 and 0.1% BSA) for 30 min at room temperature (20-22 °C) . Ovaries were incubated with primary antibodies over night at 4 °C diluted in BBX (antibodies to Piwi, Aub and Ago3, 1:500; antibodies to Armi and I element, 1:1,000; antibodies to Tudor, 1:10; antibod ies to SpnE, 1:50). After four PBT washes secondary antibodies were incubated 5 h at room temperature diluted in BBX (1:500; Molecular Probes). Ovaries were stained with DAPI for 10 min in the second of four PBT washes. Antibodies used were: anti body to Piwi, antibody to Aub and antibody to AGO3 (ref. 19 ); antibody to Tudor, antibody to SpnE 20 ; antibody to Armi 21 and antibody to I element (gift from D. Finnegan; University of Edinburgh). For the sterility test, ten 3-5dayold female flies were premated with wildtype males overnight in small cages on apple juice plates with yeast paste. Apple juice plate was changed without anesthetizing flies. After 18 h at 25 °C, the flies were removed and the number of laid eggs was counted (typically ~200 eggs). Fortyeight hours later hatched and nonhatched eggs were determined.
Additional information on the phenotypic analyses of RNAi reagents is available in Supplementary Figures 7 and 8 b-elimination. The chemical structure of the 3′ termini of small RNAs was analyzed as described previously 22 . In brief, RNA from immunoprecipitates or 25 µg of total RNA from S2 cells treated with the indicated dsRNAs (17.5 µl total volume for each sample) was incubated at room temperature for 30 min with 5 µl 5× borate buffer (148 mM borax and 148 mM boric acid; pH 8.6) supplemented with 3.125 µl freshly prepared 200 mM NaIO 4 . We added 5 µl of 50% glycerol to quench nonreacted sodium periodate by incubating for an additional 15 min at room tem perature. Samples were then vacuumdried and dissolved in 60 µl 1× borax buffer (30 mM borax, 30 mM boric acid and 50 mM NaOH; pH 9.5). βelimination was carried out by incuba tion for 2 h at 45 °C. RNAs were ethanolprecipitated and resolved in 1× gel loading buffer.
Northern blotting. Northern blotting was carried out as described previously 23, 24 . In brief, total RNAs from knockdown cells were isolated using TRIzol (Invitrogen). We separated 30 µg total RNAs from cultured cells (with or without βelimination) or RNAs from immunoprecipitations on 15% denaturing poly acrylamide gels and transferred to HybondN+ membranes (Amersham Biosciences) in 1× TBE buffer. Small RNAs were UVlight crosslinked to the membrane and prehybridized in ULTRAhybOligo buffer (Ambion) for 1 h. DNA probes complementary to the indicated strands were 5′ radiolabeled and added to the hybridization buffer (hybridization for 6 h at 30 °C). Membranes were washed 4 times in 1× SSC with 0.1% SDS at 30 °C and exposed to PhosphorImager screens (GE Healthcare) for 12-48 h. Membranes were stripped by heating in 0.2× SSC containing 0.1% SDS in a microwave twice. Sequences of the oligonucleotide probes are listed in Supplementary Note 3.
Immunoprecipitation. Cell extracts were prepared, evenly split and immunoprecipitated using antibodies to AGO1 (Abcam) or the Flag epitope (Sigma), respectively, as previously described 23 . RNAs were recovered from the immunoprecipitated samples using TRIzol and used for northern blotting.
Transposon qPCR analysis. Total RNA was extracted from ovaries of 3-5dayold flies using TRIzol. cDNA was prepared with random primers. qPCR was performed using Maxima SYBR Green/ROX qPCR Master mix (Fermentas). Calculation of steadystate RNA levels was calculated applying the 2 −∆∆Ct method 25 . Rp49 was used for normalization of all samples, and fold enrichments were calculated in comparison to an shRNA knockdown targeting the white gene. Fold changes in steadystate transcript levels and s.d. were calculated from three biological replicates. Primer sequences are available in Supplementary Note 3.
Small RNA libraries. Small RNAs were cloned as described previously 19 . For this study, the following small RNA libraries from total RNAs were prepared: 19nucleotide (nt) to 24nt from S2 cells transfected with shRNA to dlg1 (shRNA-dlg1); 19nt to 24nt from S2 cells transfected with shRNA-N; and 19nt to 24nt from S2 cells transfected with shRNA-dpp. For each construct, ~4 × 10 6 S2NP cells were transfected with 2 µg of Valium20shRNA construct and 1 µg of pMTGal4 plasmid. ShRNA expression in cells was induced by adding 500 µM CuSO 4 2 d after transfection. Total RNA was isolated using TRIzol 24 h after induction. Libraries were sequenced inhouse using the Illumina GAII sequencing platform.
Bioinformatic analysis of small RNA libraries. The analysis of small RNA libraries was performed as previously described 26 . Illumina reads were stripped of the 3′ linker and collapsed, and the resulting small RNA sequences were matched without mis matches to the Drosophila release 5 genome and to the genomes of Drosophila C virus, Flock house virus and Cricket paralysis virus with up to three mismatches. Only reads that met these conditions were analyzed further. For annotations we used a combination of University of California Santa Cruz genome browser, miRBase and Flybase tracks for proteincoding genes, repeats or transposons, noncoding RNAs and microRNAs as well as custom tracks (for shRNAs, synthetic markers, endosiRNAs from structured loci, miR and miR* strands) with different priorities (annotation prior ity list is available upon request). For comparison of small RNA counts between libraries, reads were normalized to the same total number after bioinformatic removal of sequences matching to synthetic cloning markers or assumed degradation products of abundant cellular RNAs (rRNAs, snoRNAs and tRNAs). Heatmaps were computed by plotting the abundance and ratio of individual miR, miR* and shRNA strands in each library.
Construction of the shRNA library. An shRNA library repre senting 83,256 unique synthetic hairpins was synthesized on four custom 22K Agilent microarrays 13 . The library covered all 14,208 annotated genes (excluding small RNA and noncoding RNA genes) of the Drosophila release 5 genome with up to six shRNAs per gene (14,138 genes were covered by six hairpins, and 14,147 genes were covered by five hairpins). Hairpin constructs were based on the miR1 backbone and essentially resembled those described above with perfect complementarity between guide and passenger strands. Additional sequence was attached on both ends for PCR amplification. In addition, to eliminate off target effects only shRNAs that lacked sequence complementarity to annotated microRNA 'seed' sequences were considered. DNA pools from microarray chips were amplified 13 and cloned into Valium20 and Valium22 destination vectors. Plasmid DNA was transformed, clones were picked (160,000 individual clones per destination vector), and resulting transformants were multiplexed using DNA Sudoku 14 at Open Biosystems. Pools were barcoded via PCR, and amplicons were sequenced inhouse using the
